NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $926,315 | -36.5% | 9,094 | -37.1% | 0.19% | -31.4% |
| Q2 2023 | $1,459,865 | +9.7% | 14,467 | 0.0% | 0.28% | +8.6% |
| Q1 2023 | $1,330,964 | -5.9% | 14,467 | -7.2% | 0.26% | -12.1% |
| Q4 2022 | $1,414,869 | +25.7% | 15,596 | +5.2% | 0.29% | +14.6% |
| Q3 2022 | $1,126,000 | -25.2% | 14,820 | -16.7% | 0.25% | -15.1% |
| Q2 2022 | $1,505,000 | +1.2% | 17,801 | +5.0% | 0.30% | +22.6% |
| Q1 2022 | $1,487,000 | +16.1% | 16,947 | +15.7% | 0.24% | +24.0% |
| Q4 2021 | $1,281,000 | +17.7% | 14,647 | +10.0% | 0.20% | +18.1% |
| Q3 2021 | $1,088,000 | -42.9% | 13,310 | -36.3% | 0.17% | -43.2% |
| Q2 2021 | $1,907,000 | +42.3% | 20,906 | +33.4% | 0.29% | +23.7% |
| Q1 2021 | $1,340,000 | – | 15,671 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |